<?xml version='1.0' encoding='utf-8'?>
<document id="30583636"><sentence text="[Effects of Dendrobium huoshanense on expressions and activities of hepatic microsomal cytochrome P450s in mice]." /><sentence text="This study was carried out to investigate the effect of oral administration of Dendrobium huoshanense on the expressions and activities of hepatic microsomal cytochrome P450s in mice, and to provide a reference for the evaluation of drug-drug interactions between D" /><sentence text=" huoshanense and clinical drugs" /><sentence text=" The C57BL/6 mice were randomly divided into blank control group, D" /><sentence text=" huoshanense low dose group (crude drug 1" /><sentence text="25 g·kg⁻¹), D" /><sentence text=" huoshanense high dose group (crude drug 7" /><sentence text="5 g·kg⁻¹), and phenobarbital positive control group (0" /><sentence text="08 g·kg⁻¹)" /><sentence text=" Each group was intragastrically administered with drugs for 2 weeks" /><sentence text=" The mice were sacrificed and their liver microsomes were prepared" /><sentence text=" The expressions of major subtypes of P450 enzyme were determined by Western blot and the probe drugs were used to detect the enzyme activities of P450 subtypes with protein expression changes" /><sentence text=" Western blot analysis showed that the protein expressions of CYP1A1, CYP1A2 and CYP2B in liver tissues were up-regulated in D" /><sentence text=" huoshanense-treated group" /><sentence text=" In vitro enzyme activity tests showed that there were no significant difference in metabolism of 7-ethoxyresorufin (a probe drug for CYP1A1) and bupropion (a probe drug for CYP2B) between D"><entity charOffset="98-115" id="DDI-PubMed.30583636.s15.e0" text="7-ethoxyresorufin" /><entity charOffset="146-155" id="DDI-PubMed.30583636.s15.e1" text="bupropion" /><pair ddi="false" e1="DDI-PubMed.30583636.s15.e0" e2="DDI-PubMed.30583636.s15.e0" /><pair ddi="false" e1="DDI-PubMed.30583636.s15.e0" e2="DDI-PubMed.30583636.s15.e1" /></sentence><sentence text=" huoshanense group and control group"><entity charOffset="1-12" id="DDI-PubMed.30583636.s16.e0" text="huoshanense" /></sentence><sentence text=" The metabolism of phenacetin (a probe drug for CYP1A2) showed a statistical difference in rate Vmax, and it was significantly increased by approximately 20% in D"><entity charOffset="19-29" id="DDI-PubMed.30583636.s17.e0" text="phenacetin" /></sentence><sentence text=" huoshanense group as compared with the blank control group, and the clearance CLint in treated group was also increased by about 32%"><entity charOffset="1-12" id="DDI-PubMed.30583636.s18.e0" text="huoshanense" /></sentence><sentence text=" Therefore, oral administration of D" /><sentence text=" huoshanense had no effects on the activities of most hepatic P450 enzymes in mice, with no drug-drug interaction related to the P450 enzyme system in most clinical drugs theoretically" /><sentence text=" However, oral administration of D" /><sentence text=" huoshanense may accelerate the metabolism of CYP1A2-catalyzed drugs, which needs to be considered in clinical practice" /><sentence text="" /></document>